Harbin Gloria Pharmaceuticals Co., Ltd
SZSE:002437.SZ
2.21 (CNY) • At close October 26, 2023
Overview | Financials
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operationele Activiteiten: | |||||||||||||||||
| Nettowinst
| 120.334 | -289.518 | 53.837 | 408.677 | -2,654.938 | 128.772 | 305.27 | 728.399 | 701.032 | 455.66 | 229.604 | 163.471 | 116.506 | 154.713 | 130.235 | 105.951 | 74.762 |
| Afschrijvingen & Amortisatie
| 108.372 | 130.045 | 144.497 | 149.164 | 181.355 | 184.281 | 175.994 | 154.582 | 143.597 | 92.417 | 61.739 | 26.255 | 21.306 | 16.127 | 11.444 | 9.49 | 7.772 |
| Uitgestelde Inkomstenbelasting
| 12.007 | -9.262 | 4.578 | 120.43 | -35.425 | -52.348 | -41.948 | -14.644 | -8.011 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Aandelen Gebaseerde Vergoedingen
| 0 | 0 | 0 | 39.781 | 0 | 18.157 | 21.814 | 21.911 | 20.479 | 3.363 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Verandering in Werkkapitaal
| -65.291 | -24.805 | -23.443 | -0.167 | 68.357 | 372.272 | -83.625 | -33.844 | -273.838 | 91.472 | 173.414 | 44.314 | -5.731 | -70.995 | 22.741 | -61.567 | -25.458 |
| Vorderingen
| 63.571 | 55.139 | 133.553 | -9.512 | 48.748 | -324.921 | -66.411 | 1,883.882 | -262.35 | 119.558 | -65.309 | -4.014 | 0 | 0 | 0 | 0 | 0 |
| Voorraden
| 35.444 | 120.411 | 22.091 | 27.185 | -44.662 | 17.979 | -200.332 | 1.573 | -61.822 | 25.336 | -32.229 | 4.936 | -19.209 | -29.697 | -3.631 | -5.157 | 0.438 |
| Crediteuren
| -97.863 | -191.093 | -183.665 | -138.269 | 99.698 | 731.562 | 225.066 | -1,904.656 | 41.072 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Overig Werkkapitaal
| -66.444 | -9.262 | 4.578 | 120.43 | -35.425 | 354.292 | 116.707 | -35.418 | -212.016 | 66.136 | 205.643 | 39.378 | 13.478 | -41.299 | 26.372 | -56.41 | -25.896 |
| Overige Niet-Contante Posten
| 320.959 | 445.893 | 99.29 | -705.122 | 3,015.592 | 477.437 | 254.156 | 191.35 | 131.257 | 34.488 | -11.736 | -28.151 | -3.474 | 12.748 | 6.395 | 3.936 | -4.815 |
| Kasstroom uit Operationele Activiteiten
| 280.79 | 261.616 | 274.181 | 12.764 | 610.366 | 1,162.761 | 651.795 | 1,040.487 | 702.047 | 674.037 | 453.02 | 205.889 | 128.607 | 112.593 | 170.815 | 57.809 | 52.261 |
| Investeringsactiviteiten: | |||||||||||||||||
| Investeringen in Materiële Vaste Activa
| -29.621 | -33.013 | -34.512 | -43.663 | -48.428 | -104.339 | -194.632 | -185.342 | -283.096 | -125.894 | -163.347 | -144.366 | -166.904 | -240.879 | -61.47 | -38.076 | -13.175 |
| Netto Overnames
| -45.07 | 2.876 | 74.92 | 1,025.136 | -0.34 | 23.952 | -999.525 | -1,125.803 | -1,117.83 | -1,614.055 | -415.484 | 0.036 | -13.261 | 0 | 0 | 0.38 | 0 |
| Aankoop van Beleggingen
| -405.193 | -695.32 | -1,521.36 | -1,300.131 | -1,537.681 | -852.429 | -3,055.463 | -4,011.911 | -5,554.392 | -1,946.719 | -648 | -1,178.5 | 0 | 0 | -70 | -40.27 | -8.757 |
| Verkoop/verval van Beleggingen
| 508.2 | 461.52 | 1,559.175 | 1,317.08 | 1,619.942 | 631.979 | 3,002.278 | 3,727.844 | 5,402.36 | 2,194.015 | 476.449 | 927.104 | 0 | 0 | 0 | 40 | 14.267 |
| Overige Investeringsactiviteiten
| 124.001 | 40.054 | 3.042 | 8.346 | 37.337 | 133.485 | -201.957 | 75.919 | -94.268 | 1.397 | 42.383 | -38 | 0.075 | -240.879 | 6.95 | 20 | -20 |
| Kasstroom uit Investeringsactiviteiten
| 28.315 | -223.883 | 81.265 | 1,006.769 | 70.829 | -167.353 | -1,449.299 | -1,519.294 | -1,647.226 | -1,491.257 | -708 | -433.725 | -180.089 | -240.879 | -124.52 | -17.966 | -27.665 |
| Financieringsactiviteiten: | |||||||||||||||||
| Schuldaflossingen
| -785.902 | -1,659.02 | -1,672.485 | -2,981.81 | -2,634.699 | -2,562.314 | -2,812.734 | -1,799 | -1,830 | -150 | -25 | -5 | 0 | -92 | -52 | -35 | -26.339 |
| Uitgifte van Gewone Aandelen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Terugkoop van Gewone Aandelen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Uitgekeerde Dividenden
| -43.808 | -68.762 | -70.935 | -134.482 | -26.377 | -186.626 | -263.855 | -254.933 | -154.66 | -59.478 | -168.36 | -2.116 | -70 | -3.694 | -40.014 | -53.345 | -5.884 |
| Overige Financieringsactiviteiten
| -43.808 | 1,515.233 | 2,105.008 | 1,460.281 | 2,542.963 | 1,966.743 | 3,597.695 | 2,479.222 | 2,886.544 | 1,257.989 | 15.556 | 46.134 | 34.68 | 1,674.336 | 91.398 | 49.389 | 15.642 |
| Kasstroom uit Financieringsactiviteiten
| -829.71 | -212.549 | 361.588 | -1,656.011 | -263.95 | -782.197 | 521.106 | 425.289 | 901.884 | 1,048.511 | -177.804 | 39.018 | -35.32 | 1,578.642 | -0.616 | -38.955 | -16.58 |
| Overige Informatie: | |||||||||||||||||
| Effect van Wisselkoersveranderingen op Kas
| 0.987 | 11.925 | -1.574 | -2.859 | -2.165 | 7.782 | -10.583 | 3.897 | 0.001 | 0 | 0.002 | -0 | 0.002 | 0.001 | 0 | -0 | 0 |
| Netto Kasstroomverandering
| -526.467 | -162.891 | 715.459 | -639.338 | 415.079 | 220.994 | -286.981 | -49.62 | -43.294 | 231.291 | -432.781 | -188.819 | -86.8 | 1,450.357 | 45.679 | 0.888 | 8.015 |
| Kaspositie aan het Einde van de Periode
| 711.275 | 1,230.621 | 1,393.513 | 678.053 | 1,317.391 | 902.312 | 681.318 | 968.299 | 1,017.919 | 1,061.214 | 829.923 | 1,262.704 | 1,451.523 | 1,538.323 | 87.966 | 42.287 | 41.399 |